War in Tigray erased measles surveillance and left young children unvaccinated
Surveillance data show reported measles cases from Tigray collapsed during the 2020–2022 war; afterward the median age of infection fell to five years and the odds a case was unvaccinated stayed sharply raised.
| Group | Value (years) |
|---|---|
| During conflict (2020–2022) | 24 |
| After conflict (2023–2024) | 5 |
The 2020–2022 war in Tigray did not just interrupt measles vaccination in the Ethiopian region — it made the resulting damage invisible, according to an analysis of national surveillance data [s1]. During the fighting, the number of measles cases reported from Tigray fell to 0·01% of Ethiopia's national total, a drop the authors read as near-total collapse of surveillance rather than an absence of disease [s1].
What that collapse concealed surfaced once reporting resumed. In the recovery period, the median age of a reported measles case in Tigray fell to five years, and confirmed cases were far more likely to be in children who had never received a measles vaccine [s1]. Both are the fingerprints of a cohort of susceptible young children that had been building unseen.
What the study did
Researchers conducted a retrospective longitudinal analysis of Ethiopia's national case-based measles surveillance data from 2018 to 2024, covering 69,866 records [s1]. They split the period into three phases — pre-conflict (2018–2019), the conflict peak (2020–2022) and post-conflict recovery (2023–2024) — and compared surveillance reporting, the age distribution of cases and vaccination status across them, using the pre-conflict years as the reference [s1].
The findings
The first result is the near-disappearance of Tigray from the national numbers: during the conflict peak, cases reported from the region amounted to 0·01% of the national total, consistent with a surveillance system that had stopped functioning rather than a population that had stopped getting measles [s1]. The system's degradation showed in its record-keeping too — during the conflict peak, 50% of confirmed cases in Tigray were missing sex-disaggregated data [s1].
The second result is the paediatric shift. After hostilities ended, the median age of infection in Tigray fell from 24·0 years during the conflict to 5·0 years in the post-conflict period (p < 0·0001) — a change not seen in other regions of Ethiopia [s1]. Measles concentrating in young children is what happens when routine immunisation lapses and susceptibility accumulates in a birth cohort that missed its shots.
The third result quantifies that immunity gap directly. Compared with the pre-conflict baseline, the adjusted odds that a confirmed measles case was zero-dose — in a child who had received no measles vaccine at all — were 71·43 times higher during the conflict peak (95% CI 14·1–1000·0), and remained 2·49 times higher during the recovery period (1·17–5·52) [s1]. The enormous confidence interval on the wartime figure reflects how few usable records the collapsed system produced; the post-conflict estimate is far more precise, and it shows the elevation persisting after the war formally ended.
The wider toll on mothers and infants
Measles surveillance is one thread of a broader unravelling. A separate retrospective cohort of 1,763 mothers at two hospitals in Mekelle found that the incidence of low birth weight nearly doubled over the same window, from 8·6% before the war to 17·2% during it (p < 0·001), with mothers who delivered during the war more than twice as likely to have a low-birth-weight infant (adjusted odds ratio 2·22, 95% CI 1·64–3·00) [s2]. The two datasets describe the same health system failing along different axes — antenatal care and routine immunisation alike.
Why it matters beyond Tigray
The practical warning is about timing. A susceptible cohort that builds during a conflict does not announce itself while surveillance is down; it becomes visible only afterward, as outbreaks in young children — by which point the window for quiet catch-up vaccination has narrowed. The authors' conclusion is that post-conflict recovery needs both resilient surveillance systems and targeted catch-up vaccination, precisely because the damage is largest at the moment it is hardest to see [s1].
The measured elevation in zero-dose odds through the recovery period [s1] is the concrete form of that risk: the children who missed measles vaccine during the war were, on this evidence, still under-immunised after it. That is a solvable problem, but only if the surveillance that would flag it is rebuilt first.
This article is informational and is not medical advice.
Sources
- [s1] "Effect of armed conflict on measles surveillance and zero-dose vaccination status in Tigray, Ethiopia, 2018–2024," Conflict and Health, 3 August 2026. https://doi.org/10.1186/s13031-026-00827-9
- [s2] "The impact of the Tigray War on the incidence of low birth weight in Tigray, Ethiopia: A retrospective cohort study," PLOS Global Public Health, 10 August 2026. https://doi.org/10.1371/journal.pgph.0006298
Sources
- Effect of armed conflict on measles surveillance and zero-dose vaccination status in Tigray, Ethiopia, 2018–2024 — Conflict and Health , August 3, 2026
- The impact of the Tigray War on the incidence of low birth weight in Tigray, Ethiopia: A retrospective cohort study — PLOS Global Public Health , August 10, 2026
More on
WHO's Eastern Mediterranean region is off track on measles and rubella, study finds
Measles incidence edged up and rubella more than doubled across 22 countries in 2023–2024, with outbreaks in Yemen, Iraq and Afghanistan driving the trend as second-dose coverage stalled.
Conflict is stalling child vaccination across the Sahel, WHO data show
By 2023, 22% of children in Mali and 16% in Chad had received no routine vaccine at all, an analysis of WHO figures found, with measles coverage stuck below 90% across most of the belt.
Lebanon investigated only 52% of suspected measles cases adequately, a review finds
An analysis of a decade of surveillance data shows the system leans heavily on hospitals and misses cases in the community — the weakness that lets measles circulate undetected between outbreaks.
Childhood vaccine coverage stalled in 2025, leaving 13.5 million unvaccinated
WHO and UNICEF estimates put DTP3 coverage at 85% for a second year running. Yellow fever protection sits at 53% in at-risk countries and HPV at 33% in girls, both far below target.